Search

Your search keyword '"Rawi, Reda"' showing total 87 results

Search Constraints

Start Over You searched for: Author "Rawi, Reda" Remove constraint Author: "Rawi, Reda" Database Unpaywall Remove constraint Database: Unpaywall
87 results on '"Rawi, Reda"'

Search Results

1. Cholesterol reduction by immunization with a PCSK9 mimic

2. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

3. Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection

4. Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site

5. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes

6. Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases

7. Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design

8. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide

9. Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain

10. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization

11. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency

12. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

13. Antibodies as drugs—a Keystone Symposia report

14. Cryo-EM structures of prefusion SIV envelope trimer

15. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability

16. Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite

17. Highly protective antimalarial antibodies via precision library generation and yeast display screening

18. Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site

20. In Silico Improvement of Highly Protective Anti-Malarial Antibodies

21. Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2

22. Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses

23. A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

24. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability

25. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies

27. Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces

28. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies

29. Blocking α 4 β 7 integrin delays viral rebound in SHIV SF162P3 -infected macaques treated with anti-HIV broadly neutralizing antibodies

30. Augmenting Neutralization breadth against Diverse HIV-1 by increasing the Ab-Ag interface on V2

32. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography

33. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses

34. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

35. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody

36. Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite

37. Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains

38. Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies

39. Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation

40. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

41. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

42. Impact of glycan positioning on HIV-1 Env glycan shield density, function, and antibody recognition

43. VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage

44. Impact of Glycan Positioning on HIV-1 Env Glycan Shield Density, Function, and Antibody Recognition

45. Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates

47. Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

48. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting

49. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

50. Improvement of antibody functionality by structure-guided paratope engraftment

Catalog

Books, media, physical & digital resources